Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-24-028869
Filing Date
2024-06-04
Accepted
2024-06-04 18:30:41
Documents
2
Period of Report
2024-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 1389
2 EXHIBIT 24 ef20030578_ex24.htm EX-24 9534
  Complete submission text file 0001140361-24-028869.txt   12442
Mailing Address C/O ESPERION THERAPEUTICS, INC. 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address
Braunstein Scott (Reporting) CIK: 0001643875 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40493 | Film No.: 241020006

Mailing Address 524 BROADWAY NEW YORK NY 10013
Business Address WALLSTRASSE 16 BERLIN 2M 10179 (617)-699-5876
ATAI Life Sciences N.V. (Issuer) CIK: 0001840904 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)